ANALISIS RASIO PROFITABILITAS UNTUK MENILAI KINERJA KEUANGAN PADA PERUSAHAAN FARMASI YANG TERDAFTAR
Abstract
This study aims to determine the analysis of profitability ratioson the financial performance of pharmaceutical companies listed on the Indonesia Stock Exchange (IDX). This research uses quantitative research methods with a causal approach. The samples in the 2018-2020 study used 10 samples from pharmaceutical companies which were taken based on saturated sampling techniques. Data analysis using panel data linear regression analysis. The results of the t- test study show that Gross Profit Margin (GPM) has no positive and significant effect on the financial performance (ROE) of pharmaceutical companies, based on the Net Profit Margin (NPM) which has a significant positive effect on the financial performance (ROE) of pharmaceutical companies, based on Return On Assets (ROA) has a positive effect on the financial performance (ROE) of pharmaceutical companies. The results of the F test study show that GPM has no positive and significant effect on ROE of financial performance, while NPM, ROA has a positive and significant effect on ROE of pharmaceutical company financial performance.
